REQUEST A DEMO
Total
USD $0.00
Search more companies

Leibi Medical S.R.O. (Czech Republic)

Main Activities: Real Estate
Full name: Leibi Medical S.R.O. Profile Updated: December 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Leibi Medical S.R.O. is an enterprise in Czech Republic, with the main office in Prague. The company operates in the Real Estate sector. It was first established on January 07, 2015. In its most recent financial highlights, the company reported a net sales revenue drop of 12.13% in 2024. There was a total growth of 7.59% in Leibi Medical S.R.O.’s total assets over the same period. In 2024, Leibi Medical S.R.O.’s net profit margin increased by 0.25%.

Headquarters
Parikova 354/5
Prague; The City of Prague; Postal Code: 19000

Contact Details: Purchase the Leibi Medical S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Leibi Medical S.R.O. report to view the information.
Financial Auditors:
Purchase the Leibi Medical S.R.O. report to view the information.
Incorporation Date:
January 07, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Leibi Medical S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-12.13%
Total operating revenue
-12.13%
Operating profit (EBIT)
11.52%
EBITDA
-0.93%
Net Profit (Loss) for the Period
9.29%
Total Assets
7.59%
Total Equity
46.25%
Operating Profit Margin (ROS)
0.49%
Net Profit Margin
0.25%
Return on Equity (ROE)
-10.69%
Debt/Equity
70.64%
Quick Ratio
0.69%
Cash Ratio
0.25%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?